Scott W Burchiel

Title: Scott W Burchiel: Innovator in Cancer Detection Technologies

Introduction

Scott W Burchiel is a notable inventor based in Albuquerque, NM (US). He has made significant contributions to the field of cancer detection through his innovative patents. With a total of 3 patents, Burchiel's work focuses on the development of radiolabeled antibody compositions that enhance the detection of tumors in the human body.

Latest Patents

Burchiel's latest patents include a composition and method for detecting cancer using technetium-labeled F(ab').sub.2 or Fab fragments of antibodies. These antibodies target specific tumor-associated antigens, such as human chorionic gonadotropin (hCG) and carcinoembryonic antigen (CEA). When injected into a patient, the radiolabeled antibodies accumulate at tumor sites, allowing for detection through external gamma scintigraphy. This method not only aids in monitoring and localization but also enhances the detection of smaller tumors through a double antibody approach.

Career Highlights

Throughout his career, Scott W Burchiel has worked with various organizations, including University Patents, Inc. and Serono Laboratories, Inc. His innovative work has positioned him as a key figure in the development of cancer detection technologies.

Collaborations

Burchiel has collaborated with notable individuals in his field, including David R Crockford and Buck A Rhodes. These partnerships have contributed to the advancement of his research and the successful implementation of his patented technologies.

Conclusion

Scott W Burchiel's contributions to cancer detection through innovative patent developments highlight his role as a significant inventor in the medical field. His work continues to impact the way tumors are detected and monitored, showcasing the importance of innovation in healthcare.